TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
AstraZeneca AB
Closing information (x1000 EUR)
Closing information | 2021/12 | 2020/12 | 2019/12 |
Turnover |
11,153,233
|
10,687,920
|
8,383,396 |
Financial expenses |
45,566
|
99,925
|
64,024 |
Earnings before taxes |
2,251,024
|
3,598,605
|
3,588,023 |
EBITDA |
2,514,643
|
3,728,319 | |
Total assets |
30,905,260
|
31,590,834
|
29,775,916 |
Current assets |
3,124,603
|
2,384,458
|
2,200,008 |
Current liabilities |
1,980,952
|
2,363,337
|
1,481,176 |
Equity capital |
25,573,898
|
26,072,500
|
24,552,105 |
- share capital |
200,843
|
204,633
|
196,864 |
Employees (average) |
6,814
|
6,633
|
6,150 |
Financial ratios
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Solvency |
82.7%
|
82.5%
![]() |
82.5% |
Turnover per employee |
1,637
|
1,611
|
1,363 |
Profit as a percentage of turnover |
20.2%
|
33.7%
|
42.8% |
Return on assets (ROA) |
7.4%
|
11.7%
|
12.3% |
Current ratio |
157.7%
|
100.9%
|
148.5% |
Return on equity (ROE) |
8.8%
|
13.8%
|
14.6% |
Change turnover |
663,251
|
1,973,699
|
2,892,865 |
Change turnover % |
6%
|
23%
|
53% |
Chg. No. of employees |
181
|
483
|
308 |
Chg. No. of employees % |
3%
|
8%
|
5% |
Total value of public sale
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.